887 results on '"Kasprzak, Jarosław D."'
Search Results
52. Acute myocardial injury as a sole presentation of COVID-19 in patient without cardiovascular risk factors
53. Left atrial volume changes during exercise stress echocardiography in heart failure and hypertrophic cardiomyopathy
54. Myocardial Velocities as Markers of Diastolic Function
55. Ocena i następstwa nieprawidłowej masy ciała--jak wyjaśnić paradoks otyłości?
56. Pre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022
57. A report from the American Heart Association Scientific Sessions 2021
58. Analiza porównawcza ilościowej oceny funkcji skurczowej lewej komory z zastosowaniem metod echokardiograficznych
59. Age-Adjusted D-Dimer Levels May Improve Diagnostic Assessment for Pulmonary Embolism in COVID-19 Patients
60. Comparison of Sulfur Hexafluoride Microbubble (SonoVue)-Enhanced Myocardial Contrast Echocardiography With Gated Single-Photon Emission Computed Tomography for Detection of Significant Coronary Artery Disease: A Large European Multicenter Study
61. Intramural atrial haematoma as a complication of the percutaneous atrial septal defect closure
62. Handheld ultrasound in cardiology: Current perspective.
63. The influence of lidocaine topical anesthesia during transesophageal echocardiography on blood methemoglobin level and risk of methemoglobinemia
64. Continuous hands-free monitoring of echocardiographic exercise test using probe fixation device
65. COVID-tsubo: takotsubo syndrome in patient hospitalized due to the SARS-CoV-2 infection
66. The latest scientific reports in the field of invasive cardiology: Transcatheter Cardiovascular Therapeutics (TCT) Congress, Orlando, November 4–6, 2021
67. Pharmacological Cardioversion in Patients with Recent-Onset Atrial Fibrillation and Chronic Kidney Disease Subanalysis of the CANT II Study
68. Management of patients after heart valve interventions. Expert opinion of the Working Group on Valvular Heart Diseases, Working Group on Cardiac Surgery, and Association of Cardiovascular Interventions of the Polish Cardiac Society
69. Efficacy and safety of antazoline for cardioversion of atrial fibrillation: propensity score matching analysis of multicenter registry (CANT II Study)
70. An expert opinion of the Heart Failure Association of the Polish Cardiac Society on the 2021 European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure: Heart failure guidelines from a national perspective
71. Complexity of changes in right ventricular morphology and function in patients undergoing cardiac surgery — 3D echocardiographic study
72. Management of dyslipidemia in Poland: Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. The Fourth Declaration of Sopot
73. Right Heart Pulmonary Circulation Unit Response to Exercise in Patients with Controlled Systemic Arterial Hypertension: Insights from the RIGHT Heart International NETwork (RIGHT-NET)
74. Leczenie dyslipidemii w Polsce — interdyscyplinarne stanowisko grupy ekspertów wsparte przez Sekcję Farmakoterapii Sercowo-Naczyniowej Polskiego Towarzystwa Kardiologicznego. IV Deklaracja Sopocka
75. Circumflex Origin from Right Coronary Artery—The Anomaly That Should Not Be Omitted during Echocardiography—”Crossed Aorta” and “Bleb Sign” Presentation after Stents Implantation
76. Left Atrial Dysfunction Assessed by Two-Dimensional Speckle Tracking Echocardiography in Patients with Impaired Left Ventricular Ejection Fraction and Sleep-Disordered Breathing
77. The assessment of right atrial function with the use of speckle tracking echocardiography.
78. The use of GLP-1 analogs in treatment of diabetes in patients with cardiovascular diseases. The expert opinion of the Working Group of Cardiovascular Pharmacotherapy of the Polish Cardiac Society.
79. Cancer and Infective Endocarditis: Characteristics and Prognostic Impact
80. Advances in heart failure pharmacotherapy and cardio-vascular prevention: reports from The Congress of European Society of Cardiology 2020
81. The impact of the COVID-19 pandemic on the echocardiographic services and training in Poland
82. Left atrial strain — a current clinical perspective
83. Psoriasis and Atherosclerosis—Skin, Joints, and Cardiovascular Story of Two Plaques in Relation to the Treatment with Biologics
84. Artificial Intelligence-Powered Measurement of Left Ventricular Ejection Fraction Using a Handheld Ultrasound Device
85. Giant Aneurysm of Aortic Right Coronary Sinus: Diagnostic Doubts Related to Presentation of Valsalva Sinus Aneurysm in Transthoracic Echocardiography
86. Delayed longitudinal myocardial function recovery after dobutamine challenge as a novel presentation of myocardial dysfunction in type 2 diabetic patients without angiographic coronary artery disease
87. Effect of Intravenous FX06 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction: Results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) Trial
88. Rozpoczęcie leczenia sakubitrylem/walsartanem w ramach ambulatoryjnej rehabilitacji kardiologicznej u pacjenta z niewydolnością serca w dziewiątej dekadzie życia.
89. Initiation of treatment with sacubitril/valsartan during outpatient cardiac rehabilitation program in an octogenarian with heart failure.
90. Comparative analysis of the quantitative assessment of left ventricular systolic function using echocardiographic methods.
91. Initiation of treatment with sacubitril/valsartan during outpatient cardiac rehabilitation program in an octogenarian with heart failure
92. Przeszczepienie wątroby u pacjenta z zespołem Budda-Chiariego jako czynnik poprawiający funkcję układu autonomicznego oraz obniżający ryzyko nagłego zgonu sercowego
93. N-Terminal Pro-Brain Natriuretic Peptide and Right Ventricular Diameter Are Related to Aspirin Resistance in Coronary Artery Disease Patients
94. An expert opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation and the Polish Society for Rheumatology on the diagnosis and treatment of pulmonary hypertension in patients with connective tissue disease
95. Progress in the treatment of cardiovascular diseases. News from the American Heart Association Scientific Sessions 2020
96. Comparison of coronary flow reserve feasibility in different stress echocardiography protocols: dobutamine, dipyridamole, exercise and rapid pacing
97. Jak rozpoznawać niewydolność serca z zachowaną frakcją wyrzutową. Praktyczny przewodnik Klubu 30 Polskiego Towarzystwa Kardiologicznego
98. Application of Neural Networks for the Analysis of Intravascular Ultrasound and Histological Aortic Wall Appearance—An In Vitro Tissue Characterization Study
99. Pulmonary edema prognostic score predicts in-hospital mortality risk in patients with acute cardiogenic pulmonary edema
100. Should we search for linear correlations between global strain parameters and ejection fraction?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.